Pharmaceuticals, Biotechnology and Life Sciences
AstraZeneca and Eli Lilly are abandoning the global Phase III clinical trials of lanabecestat, an oral beta secretase cleaving enzyme…
Bayer successfully completed the acquisition of Monsanto on Thursday. Shares in the U.S. company will no longer be traded on the…
BioMarin Pharmaceutical has received $20 million in milestone payments from Pfizer Inc, it said Thursday.
A clinical stage biopharmaceutical company, 4D pharma, pioneering the development of Live Biotherapeutic Products, has made a deal with a subsidiary of…
In a recent study, scientists confirmed the ability of Omyapharm to formulate orally disintegrating tablets (ODTs) with enhanced mouthfeel and…
Schreiner MediPharm developed a smart blister pack for a multinational pharmaceutical corporation, for digital patient compliance monitoring to enhance medication…
Alkermes has received a $50 million payment from Biogen after it reviewed the preliminary gastrointestinal tolerability data from the ongoing…
The U.S. Food and Drug Administration has approved Mylan’s Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance…
Bayer plans to complete the acquisition of Monsanto on June, 7, doubling the size of its agriculture business, the company…
Novartis on Sunday announced positive results from the third Phase III trial of Kisqali in advanced or metastatic breast cancer.